跳转至内容
Merck
CN

373225

Hdm2 E3 Ligase Inhibitor - CAS 414905-09-2 - Calbiochem

The Hdm2 E3 Ligase Inhibitor, also referenced under CAS 414905-09-2, controls the biological activity of Hdm2 E3 Ligase. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

别名:

Hdm2 E3 Ligase Inhibitor - CAS 414905-09-2 - Calbiochem, N-((3,3,3-Trifluoro-2-trifluromethyl)propionyl)sulfanilamide, Mdm2 E3 Ligase Inhibitor, MDM2 Inhibitor V

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C10H8F6N2O3S
化学文摘社编号:
分子量:
350.24
UNSPSC Code:
12352200
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

assay

≥95% (NMR)

form

solid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze, protect from light

color

pale yellow

solubility

DMSO: 50 mg/mL

shipped in

ambient

Quality Level

General description

A cell-permeable and reversible inhibitor of Hdm2 E3 ligase that selectively blocks Hdm2 E3-mediated ubiquitination. Has been shown to inhibit ubiquitination of p53 in vitro (IC50 = 12.7 µM using Ub-Ubc as the donor substrate). Exhibits little effect towards other ubiquitin-using enzymes (IC50 >100 µM for E1, Nedd-4, and SCF) or the auto-ubiquitination activity of Hdm2. The inhibition is non-competitive with respect to either the donor or acceptor substrate.

Biochem/physiol Actions

Cell permeable: yes
Primary Target
ubiquitination of p53 in vitro
Product does not compete with ATP.
Reversible: yes
Target IC50: 12.7 µM inhibiting ubiquitination of p53 in vitro using Ub-Ubc as the donor substrate

Packaging

Packaged under inert gas

Other Notes

Lai, Z., et al. 2002. Proc. Natl. Acad. Sci. USA99, 14734.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Standard Handling (A)

存储类别

10-13 - German Storage Class 10 to 13


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Zhihong Lai et al.
Proceedings of the National Academy of Sciences of the United States of America, 99(23), 14734-14739 (2002-10-31)
The oncoprotein hdm2 ubiquitinates p53, resulting in the rapid degradation of p53 through the ubiquitin (Ub)-proteasome pathway. Hdm2-mediated destabilization and inactivation of p53 are thought to play a critical role in a number of human cancers. We have used an

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持